Ws Management Lllp Regenxbio Inc. Transaction History

Ws Management Lllp

$1.43 Billion
Q3 2024

A detailed history of Ws Management Lllp transactions in Regenxbio Inc. stock. As of the latest transaction made, Ws Management Lllp holds 300,000 shares of RGNX stock, worth $2.39 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

300,000

Previous 379,059 20.86%

Holding current value

$2.39 Million

Previous $4.43 Million 29.03%

% of portfolio

0.22%

Previous 0.33%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$10.49 - $14.39 $829,328 - $1.14 Million	-79,059 Reduced 20.86%	300,000 $3.15 Million
Q1 2024 May 14, 2024	SELL	$12.17 - $24.61 $634,555 - $1.28 Million	-52,141 Reduced 12.09%	379,059 $7.99 Million
Q4 2023 Feb 13, 2024	SELL	$12.89 - $20.82 $2.41 Million - $3.89 Million	-186,931 Reduced 30.24%	431,200 $7.74 Million
Q3 2023 Nov 13, 2023	SELL	$16.46 - $19.99 $2.92 Million - $3.55 Million	-177,647 Reduced 22.32%	618,131 $10.2 Million
Q2 2023 Aug 10, 2023	BUY	$17.23 - $21.71 $6.87 Million - $8.66 Million	398,781 Added 100.45%	795,778 $15.9 Million
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $445,800 - $700,800	-20,000 Reduced 4.8%	396,997 $10.5 Million
Q2 2022 Aug 15, 2022	SELL	$19.35 - $35.04 $1.11 Million - $2.01 Million	-57,303 Reduced 12.08%	416,997 $10.3 Million
Q1 2022 May 12, 2022	BUY	$24.62 - $34.31 $4.65 Million - $6.48 Million	189,000 Added 66.25%	474,300 $15.7 Million
Q4 2021 Feb 11, 2022	BUY	$30.19 - $40.28 $2.25 Million - $3 Million	74,571 Added 35.39%	285,300 $9.33 Million
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $1.45 Million - $2.28 Million	-50,000 Reduced 19.18%	210,729 $8.83 Million
Q2 2021 Aug 12, 2021	SELL	$32.46 - $40.48 $2.26 Million - $2.82 Million	-69,600 Reduced 21.07%	260,729 $10.1 Million
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $2.43 Million - $3.62 Million	72,400 Added 28.07%	330,329 $11.3 Million
Q4 2020 Feb 11, 2021	SELL	$26.52 - $49.35 $4.74 Million - $8.83 Million	-178,899 Reduced 40.95%	257,929 $11.7 Million
Q2 2020 Aug 13, 2020	SELL	$27.75 - $43.44 $5.52 Million - $8.64 Million	-198,933 Reduced 31.29%	436,828 $16.1 Million
Q1 2020 May 13, 2020	SELL	$21.5 - $54.2 $1.84 Million - $4.65 Million	-85,739 Reduced 11.88%	635,761 $20.6 Million
Q4 2019 Feb 12, 2020	SELL	$34.54 - $44.87 $8.17 Million - $10.6 Million	-236,465 Reduced 24.68%	721,500 $29.6 Million
Q3 2019 Nov 13, 2019	SELL	$31.84 - $50.88 $1.33 Million - $2.12 Million	-41,763 Reduced 4.18%	957,965 $34.1 Million
Q2 2019 Aug 13, 2019	BUY	$42.0 - $59.29 $166,656 - $235,262	3,968 Added 0.4%	999,728 $51.4 Million
Q1 2019 May 13, 2019	SELL	$40.82 - $62.45 $827,013 - $1.27 Million	-20,260 Reduced 1.99%	995,760 $57.1 Million
Q4 2018 Feb 12, 2019	BUY	$39.11 - $75.15 $2.39 Million - $4.6 Million	61,208 Added 6.41%	1,016,020 $42.6 Million
Q3 2018 Nov 13, 2018	SELL	$65.0 - $82.15 $5.47 Million - $6.91 Million	-84,163 Reduced 8.1%	954,812 $72.1 Million
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $22.8 Million - $62.4 Million	838,975 Added 419.49%	1,038,975 $74.5 Million
Q1 2018 May 11, 2018	BUY	$24.05 - $37.5 $4.81 Million - $7.5 Million	200,000 New	200,000 $5.97 Million

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $344M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Ws Management Lllp with notifications on news.

Account

Ws Management Lllp Regenxbio Inc. Transaction History